Medical device marketing agency, built for specialist reach
Demand generation for medtech teams whose reps can no longer reach every specialist.
Acquiring a medtech customer costs an average of $921, among the highest of any industry (Position Digital). Meanwhile, purchasing keeps shifting from individual surgeons to hospital value-analysis committees.
We extend your reach beyond the rep network: the specialists, the committees, and the channels between them.
Compliantly, from cleared claims to CE-marked markets.
Most agencies talk about HCP marketing HCP Compass delivers verified HCP pipeline
Life-science commercial
teams that trust us
with their HCP pipeline
24 biotech, medtech, and pharma teams have started an engagement with us.
Senior operators run every account end-to-end
Why medical device marketing agencies
miss the specialists.
You have reps and a pipeline, but reach keeps shrinking. Three reasons the model breaks.
Rep enablement only.
Agencies arm the sales team and stop there. The surgeons your reps never see, and the committees behind them, decide more than the visit does.
Claims beyond clearance.
Calling a 510(k) device “FDA approved” is misbranding, and superiority claims need head-to-head data. Creative that ignores this stalls in review or draws letters.
Attribution built for e-commerce.
Device journeys run months, across surgeon education, evaluation, and procurement. Last-click models measure none of it.
Built for HCP demand across
biotech, medtech, and pharma
Six capabilities. From the brief to the verified prescriber in your CRM, every stage
runs through senior life-science marketing specialists.
Custom HCP marketing strategy
Discovery first, tactics second.
The Compass Method begins with deep audience and brand understanding before any channel gets configured.
MLR-ready content production
Compliance built into the brief, not added at the end.
Pre-cleared claim libraries. On-PI language. Fair-balance as a layout requirement.
Multi-channel surround
Seven channels, one MLR-cleared narrative.
LinkedIn, Doximity, Sermo, Meta, YouTube, curated Google Display, and email.
Verified lead generation
Every lead registry-verified at delivery.
NPPES (US). GMC, NMC, GPhC (UK). RPPS, LANR, BIG-register (EU).
CRM integration
Native push with verification metadata.
Veeva, Salesforce Health Cloud, or HubSpot.
AI search visibility
Cited by ChatGPT, Claude, and Perplexity.
HCPs research products on AI before the first sales call. We optimize for the AI citation layer.
The HCP social media: leverage channels, on cleared
narrative, four to six touchpoints a week.
The same cardiologist scrolls LinkedIn at 7am, checks Doximity at 8am, sees an Instagram ad at
lunch, watches a YouTube clinical talk in the evening. By Friday, your brand is one they recognise.
From discovery
to verified pipeline
Every engagement runs through a four-stage methodology. Understanding first. Strategy from understanding. Tactics from strategy. Verification at delivery.
Strategy
Deep audience discovery, brand context, and CRM planning. Journey mapped across channels. KPIs locked. Two-week sprint.
Create
MLR-ready content built from day one. Pre-cleared claim libraries. On-PI language. Fair-balance designed into the layout. Most assets clear MLR on first submission.
Activate
Multi-channel campaign launch by senior channel specialists. LinkedIn, Doximity, Sermo, Meta, YouTube, curated Google Display. No junior staff on channel configuration.
Convert and Verify
Every lead registry-checked at the moment of delivery. NPI, GMC, RPPS, LANR, BIG-register. Verification metadata travels with the lead into your CRM.
Frequently Asked Questions
It builds commercial demand for device manufacturers. HCP Compass runs the version generalists skip: medical device digital marketing aimed at the specialists who use, specify, and champion your device, connected to verified lead delivery in your CRM.
Purchasing power moved. Over $300 billion in US provider spending flows through group purchasing organizations, and value-analysis committees now demand clinical and economic evidence, not just surgeon preference. Marketing has to serve both the clinician and the committee behind them.
Only what your clearance supports. A 510(k) device is “cleared,” never “approved,” and superiority claims require head-to-head clinical data. In the EU, MDR requires every safety or performance claim to trace to your clinical evaluation report. We write inside those lines.
The exchange is clinical value: procedure content, training resources, and evidence specialists actually want. Every captured lead is verified against a professional registry and delivered to your CRM with the proof attached, so your reps chase clinicians, not form fills.
We do not publish a flat price because scope drives cost. Engagements start at $3,000 per month and scale with scope, with media budget separate. The consultation defines what your commercial stage needs first.
Across the long cycle it actually runs: specialist engagement and awareness in the target specialty, qualified verified leads, and rep-meeting conversion. Measured against the goal, not against last-click models built for e-commerce.
Arjun Shailly
CEO · HCP Compass
Ready to build verified pipeline
Speak with an HCP marketing specialist, not a salesperson
In our call, you will leave with clarity on:
- The content strategy that fits your specialty and commercial stage
- How to distribute that content precisely to the right HCPs
- The channels that actually map to your goals, not a generic list
- What it really takes to ship a campaign launch that converts
No pitch deck. No demos. Just the diagnostic conversation that decides whether the engagement is a fit.
The HCP marketing field guide
Four deeper guides across HCP demand generation, compliance, and measurement. Practitioner-direct, for the people who own the budget.
What Is HCP Targeted Marketing? How It Works in 2026
What is HCP targeted marketing? Every word in the definition is doing work. Take it apart and the discipline becomes vis…
HCP Marketing Best Practices: What Works in 2026
Here is the gap this post exists to close. In Deloitte’s March 2025 global survey, 82% of life science executives said…
Modular Content in Pharma: Build Once, Reuse Right
Here is the uncomfortable starting point. Most teams buy modular content to produce more assets, faster. Yet Veeva’s a…
